Life Science Today
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs.
Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
The Niche Episode 064 – Jazz, GreenLight, Thermo Fisher + PPD, AbbVie + Soliton, Eliem, COVID Update
This week, approvals for sleep and seizures across the pond, mRNA finds other SPACs, senior notes for CROs, FTC does a double take, IPOs, and boosters
Find out more at
https://thenichepod.com
Story References
https://tinyurl.com/Niche-064-1
https://tinyurl.com/Niche-064-2
https://tinyurl.com/Niche-064-3
https://tinyurl.com/Niche-064-4
https://tinyurl.com/Niche-064-5
https://tinyurl.com/Niche-064-6
https://tinyurl.com/Niche-064-7
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 063 – Medtronic, Sanofi, Adagio, Moderna, WCG, Inotiv, NAMSA, CenExel
Device acquisitions, rare disease approvals, COVID success stories, and clinical research ups and downs.
Find out more at
https://thenichepod.com
Story References
https://tinyurl.com/Niche-063-1
https://tinyurl.com/Niche-063-2
https://tinyurl.com/Niche-063-3
https://tinyurl.com/Niche-063-4
https://tinyurl.com/Niche-063-5
https://tinyurl.com/Niche-063-6
https://tinyurl.com/Niche-063-7
https://tinyurl.com/Niche-063-8
https://tinyurl.com/Niche-063-9
https://tinyurl.com/Niche-063-10
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 062 – Allergan + AbbVie, CHOP, Amgen + TeneoBio, Cidara, Viatris + Biocon, SOPHiA, Caribou, Artois
This week, look closer – with drops, controlled gene therapy, acquisitions in antibodies, new antifungals, new biosimilars, and several IPOs
Find out more at
https://thenichepod.com
Story References
https://tinyurl.com/Niche-061-1
https://tinyurl.com/Niche-061-2
https://tinyurl.com/Niche-061-3
https://tinyurl.com/Niche-061-4
https://tinyurl.com/Niche-061-5
https://tinyurl.com/Niche-061-6
https://tinyurl.com/Niche-061-7
https://tinyurl.com/Niche-061-8
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
About the Show
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 061 – Bonus Episode – Interview with Brazen Bio founders Shawn Carbonell and Brent Witgen
In this special bonus episode, Dr. Noah Goodson sits down with biotech founders Dr. Shawn Carbonell and Dr. Brent Witgen to discuss their new founder-friendly biotech incubator Brazen Bio.
Find out more at
https://thenichepod.com
Story References
https://wefunder.com/brazenbio/
https://www.linkedin.com/company/brazenbio/
https://www.brazen.bio
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 060 – PacBio + Omniome, Eli Lilly, Adverum, Seres, Pfizer + Arvinas
Sequencing technology, decentralized Alzheimer’s trials, busts in gene therapy and microbiomes, and a $2.4B oncology collaboration
Find out more at
https://thenichepod.com
Story References
https://tinyurl.com/Niche-060-1
https://tinyurl.com/Niche-060-2
https://tinyurl.com/Niche-060-3
https://tinyurl.com/Niche-060-4
https://tinyurl.com/Niche-060-5
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 059 – IRLAB + IPSEN, Merck (MSD), Pfizer, Regeneron, GSK, Erasca
Dopamine deals, Merck vaccine approval, Epipen settlements, billions in buildings, and outsized Oncology IPO.
Story References
https://tinyurl.com/Niche-059-1
https://tinyurl.com/Niche-059-2
https://tinyurl.com/Niche-059-3
https://tinyurl.com/Niche-059-4
https://tinyurl.com/Niche-059-5
https://tinyurl.com/Niche-059-6
https://tinyurl.com/Niche-059-7
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
Responses